Clincosm LogoSign in Get a demo

unresectable hepatocellular carcinoma

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn More About How WellTreatment Works When Given After

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
  • Baltimore, Maryland
  • +19 more
Oct 31, 2023

Unresectable Hepatocellular Carcinoma Trial in Nanjing (Yttrium-90 carbon microspheres SIRT)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Yttrium-90 carbon microspheres SIRT
  • Nanjing, China
    Gao-Jun Teng
Jul 20, 2023

Unresectable Hepatocellular Carcinoma, Oligometastatic Disease Trial in Beijing (SBRT plus tislelizumab and regorafenib)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Oligometastatic Disease
  • SBRT plus tislelizumab and regorafenib
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Jun 15, 2023

Unresectable Hepatocellular Carcinoma, Pembrolizumab, Lenvatinib Trial in Taipei City (Lenvatinib/Pembrolizumab plus SBRT

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
  • +3 more
  • Lenvatinib/Pembrolizumab plus SBRT combinations
  • Taipei City, Taiawn, Taiwan
    National Taiwan University Hospital
Jan 30, 2023

Unresectable Hepatocellular Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Chicago, Illinois
  • +6 more
Jan 18, 2023

Unresectable Hepatocellular Carcinoma Trial in Worldwide (TheraSphere)

Completed
  • Unresectable Hepatocellular Carcinoma
  • TheraSphere
  • Phoenix, Arizona
  • +93 more
Jan 19, 2023

Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
    • (no location specified)
    Dec 19, 2022

    Unresectable Hepatocellular Carcinoma Trial (Huaier granule, Atezolizumab + Bevacizumab, Camrelizumab+Apatinib)

    Not yet recruiting
    • Unresectable Hepatocellular Carcinoma
    • Huaier granule
    • +3 more
    • (no location specified)
    Dec 20, 2022

    BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

    Withdrawn
    • BCLC Stage B Hepatocellular Carcinoma
    • +4 more
    • Atezolizumab
    • +3 more
    • (no location specified)
    Dec 12, 2022

    Unresectable Hepatocellular Carcinoma Trial in Changsha (Donafenib Tosilate Tablets, Toripalimab Injection)

    Recruiting
    • Unresectable Hepatocellular Carcinoma
    • Donafenib Tosilate Tablets
    • Toripalimab Injection
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Nov 28, 2022

    Unresectable Hepatocellular Carcinoma Trial in Nanchang (D-TACE, HAIC, Lenvatinib)

    Recruiting
    • Unresectable Hepatocellular Carcinoma
    • Nanchang, Jiangxi, China
      The Second Affiliated Hospital of Nanchang University
    Oct 14, 2022

    Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

    Completed
    • Stage III Hepatocellular Carcinoma AJCC v8
    • +6 more
    • Yttrium Y 90 Glass Microspheres
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma Trial in United States (Cisplatin, Doxorubicin Hydrochloride,

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Unresectable Hepatocellular Carcinoma
    • Birmingham, Alabama
    • +280 more
    Sep 23, 2022

    Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

    Recruiting
    • Unresectable Hepatocellular Carcinoma
    • +3 more
    • Resin microspheres containing yttrium-90 (Y-90)
    • Mission Hills, California
    • +15 more
    Sep 15, 2022

    BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

    Not yet recruiting
    • BCLC Stage B Hepatocellular Carcinoma
    • +10 more
    • Ipilimumab
    • Nivolumab
    • Miami, Florida
    • +4 more
    Aug 23, 2022

    Unresectable Hepatocellular Carcinoma Trial (Donafenib plus Sintilimab in combination with transarterial chemoembolisation)

    Not yet recruiting
    • Unresectable Hepatocellular Carcinoma
    • Donafenib plus Sintilimab in combination with transarterial chemoembolisation
    • (no location specified)
    Aug 17, 2022

    BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

    Recruiting
    • BCLC Stage B Hepatocellular Carcinoma
    • +9 more
    • Durvalumab
    • Tremelimumab
    • Duarte, California
      City of Hope Medical Center
    Aug 15, 2022

    Unresectable Hepatocellular Carcinoma Trial (Durvalumab, Tremelimumab)

    Available
    • Unresectable Hepatocellular Carcinoma
    • (no location specified)
    Aug 12, 2022

    Advanced Adult Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v7 Trial in

    Completed
    Has Results
    • Advanced Adult Hepatocellular Carcinoma
    • +9 more
    • Doxorubicin Hydrochloride
    • +3 more
    • Birmingham, Alabama
    • +672 more
    Aug 3, 2022

    Recurrent Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8

    Recruiting
    • Recurrent Hepatocellular Carcinoma
    • +7 more
    • Scottsdale, Arizona
    • +1 more
    Jun 16, 2022

    Stage III Hepatocellular Carcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Hepatocellular

    Recruiting
    • Stage III Hepatocellular Carcinoma AJCC v8
    • +11 more
    • External Beam Radiation Therapy
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jun 1, 2022

    Unresectable Hepatocellular Carcinoma, Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou, Guanzhou, Changsha (Hepatic

    Recruiting
    • Unresectable Hepatocellular Carcinoma
    • Hepatocellular Carcinoma by BCLC Stage
    • Hepatic Arterial Infusion(mFOLFOX7) combined with Bevacizumab and Sintilimab
    • Guangzhou, Guangdong, China
    • +4 more
    May 4, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +129 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Apr 8, 2022

    Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8 Trial

    Recruiting
    • Advanced Hepatocellular Carcinoma
    • +7 more
    • Computed Tomography
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Mar 11, 2022

    Unresectable Hepatocellular Carcinoma Trial in Guangzhou (dTACE-HAIC, HAIC, dTACE-HAIC protocol)

    Recruiting
    • Unresectable Hepatocellular Carcinoma
    • dTACE-HAIC
    • +3 more
    • Guangzhou, Guangdong, China
      the Second Affiliated Hospital of Guangzhou Medical University
    Feb 22, 2022